SI
RCUS icon

Sofinnova Investments’s Arcus Biosciences RCUS Stock Holding History

Sofinnova Investments’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.2M Buy
945,690
+22,604
+2% +$559K 1.51% 24
2026
Q1 		$19.9M Sell
923,086
-173,619
-16% -$3.75M 0.76% 39
2025
Q4 		$26.1M Sell
1,096,705
-125,558
-10% -$2.56M 1.13% 33
2025
Q3 		$16.6M Buy
1,222,263
+6,247
+0.5% +$65K 0.91% 34
2025
Q2 		$9.9M Buy
1,216,016
+178,240
+17% +$1.52M 0.61% 42
2025
Q1 		$8.15M Buy
+1,037,776
New +$12M 0.53% 43
2023
Q1 		– Sell
-314,811
Closed -$6.51M – 60
2022
Q4 		$6.51M Sell
314,811
-66,534
-17% -$1.83M 0.39% 35
2022
Q3 		$9.98M Buy
+381,345
New +$10.1M 0.58% 31
2021
Q1 		– Sell
-186,278
Closed -$4.84M – 74
2020
Q4 		$4.84M Buy
+186,278
New +$4.51M 0.29% 49

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Sofinnova Investments's RCUS Position: Q2 2026 in Review

Sofinnova Investments increased its Arcus Biosciences (RCUS) stake by 2.4% in Q2 2026, buying an estimated $559K and bringing the position to 945,690 shares worth $29.2M. The position accounts for 1.51% of the portfolio, ranked #24.

Sofinnova Investments first reported a position in RCUS in Q4 2020 and has held it in 9 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Sofinnova Investments held 945,690 shares of Arcus Biosciences worth $29.2M as of Q2 2026.
  • Sofinnova Investments bought 22,604 Arcus Biosciences shares in Q2 2026, an estimated $559K.
  • Arcus Biosciences made up 1.51% of Sofinnova Investments's portfolio in Q2 2026, its #24 holding.
  • Sofinnova Investments first reported a position in Arcus Biosciences in Q4 2020 and has held it in 9 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.